Vaccinex Inc (VCNX)
5.30
-0.32
(-5.78%)
USD |
NASDAQ |
May 16, 16:00
5.30
0.00 (0.00%)
After-Hours: 20:00
Vaccinex Total Liabilities (Quarterly): 5.942M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.942M |
| September 30, 2023 | 6.427M |
| June 30, 2023 | 3.508M |
| March 31, 2023 | 2.495M |
| December 31, 2022 | 2.784M |
| September 30, 2022 | 2.294M |
| June 30, 2022 | 1.629M |
| March 31, 2022 | 1.933M |
| December 31, 2021 | 2.431M |
| September 30, 2021 | 3.299M |
| June 30, 2021 | 6.849M |
| March 31, 2021 | 7.903M |
| December 31, 2020 | 14.31M |
| Date | Value |
|---|---|
| September 30, 2020 | 14.96M |
| June 30, 2020 | 8.677M |
| March 31, 2020 | 6.62M |
| December 31, 2019 | 6.878M |
| September 30, 2019 | 6.896M |
| June 30, 2019 | 9.501M |
| March 31, 2019 | 6.959M |
| December 31, 2018 | 6.686M |
| September 30, 2018 | 6.136M |
| June 30, 2018 | 8.864M |
| March 31, 2018 | 6.544M |
| December 31, 2017 | 7.347M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.629M
Minimum
Jun 2022
14.96M
Maximum
Sep 2020
6.071M
Average
6.427M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 1.140B |
| Avinger Inc | 19.97M |
| RAPT Therapeutics Inc | 24.98M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 24.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.631M |
| Shareholders Equity (Quarterly) | -2.311M |